Skip to main content
SpringerLink
Log in

GSTP1 and MDR1 Genotypes and Central Nervous System Relapse in Childhood Acute Lymphoblastic Leukemia

  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

The probability of event-free survival of childhood acute lymphoblastic leukemia (ALL) approaches 80% or more with the use of modern multiagent chemotherapeutic regimens. One major contribution to this success has been reduction of the rate of central nervous system (CNS) relapses to less than 5%. However, heterogeneity is observed with regard to the incidence of CNS relapse in homogenously treated patient populations. One potential explanation for this heterogeneity is variation in the genetic background of these populations. Glutathione S-transferase P1 and P-glycoprotein are implicated in resistance to a variety of chemotherapeutic agents and have been localized to the blood-brain barrier. In a matched case-control study, we investigated the associations between CNS relapse in childhood ALL and the presence of phenotypically relevant single nucleotide polymorphisms within the GSTP1 (codon 105 and 114) and MDR1 genes (ABCB1; coding for Pgp; exon 26, C3435T). Significant reductions in risk of CNS relapse were observed for patients homozygous for the GSTP1 Val105 allele as well as for patients with the MDR1 3435T/T or C/T genotype. For both genotypes, the effect was restricted to patients at intermediate or high risk of treatment failure.These results suggested a modulating role for host genetic variation in the development of CNS relapse in childhood ALL treated according to Berlin-Frankfurt-Münster protocols.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Schrappe M, Reiter A, Zimmermann M, et al. Long-term results of four consecutive trials in childhood ALL performed by the ALLBFM study group from 1981 to 1995. Leukemia. 2000;14:2205–2222.

    Article  PubMed  CAS  Google Scholar 

  2. Gaynon PS, Trigg ME, Heerema NA, et al. Children’s Cancer Group trials in childhood acute lymphoblastic leukemia: 1983- 1995. Leukemia. 2000;14:2223–2233.

    Article  PubMed  CAS  Google Scholar 

  3. Pui CH, Boyett JM, Rivera GK, et al. Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St. Jude Children’s Research Hospital. Leukemia. 2000;14:2286–2294.

    Article  PubMed  CAS  Google Scholar 

  4. Pinkel D, Woo S. Prevention and treatment of meningeal leukemia in children. Blood. 1994;84:355–366.

    PubMed  CAS  Google Scholar 

  5. Eaton DL, Bammler TK. Glutathione S-transferases. In: Levy RH, Thummel KE, Trager WF, Hansten PD, Eichelbaum M, eds. Metabolic Drug Interactions. Philadelphia: Lippincott Williams & Wilkins; 2000:175–189.

    Google Scholar 

  6. Bellamy WT. P-glycoproteins and multidrug resistance. Annu Rev Pharmacol Toxicol. 1996;36:161–183.

    Article  CAS  PubMed  Google Scholar 

  7. Board PG, Webb GC, Coggan M. Isolation of a cDNA clone and localization of the human glutathione S-transferase 3 gene to chromosome bands 11q13 and 12q13-14. Ann Hum Genet. 1989;53:205–213.

    Article  CAS  PubMed  Google Scholar 

  8. Board P, Coggan M, Johnston P, Ross V, Suzuki T, Webb G. Genetic heterogeneity of the human glutathione transferases: a complex of gene families. Pharmacol Ther. 1990;48:357–369.

    Article  CAS  PubMed  Google Scholar 

  9. Hu X, Xia H, Srivastava SK, et al. Activity of four allelic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun. 1997;238:397–402.

    Article  PubMed  CAS  Google Scholar 

  10. Zimniak P, Nanduri B, Pikula S, et al. Naturally occurring human glutathione S-transferase GSTP-1 isoforms with isoleucin and valine in position 104 differ in enzymic properties. Eur J Biochem. 1994;224:893–899.

    Article  PubMed  CAS  Google Scholar 

  11. Hoffmeyer S, Burk O, von Richter O, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A. 2000;97:3473–3478.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Siegsmund M, Brinkmann U, Schaffeler E, et al. Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol. 2002;13:1847–1854.

    Article  PubMed  CAS  Google Scholar 

  13. Hitzl M, Drescher S, van der Kuip H, et al. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics. 2001;11:293–298.

    Article  PubMed  CAS  Google Scholar 

  14. Schwab M, Eichelbaum M, Fromm MF. Genetic polymorphisms of the human mdr1 drug transporter. Annu Rev Pharmacol Toxicol. 2003;43:285–307.

    Article  PubMed  CAS  Google Scholar 

  15. Carder PJ, Hume R, Fryer AA, Strange RC, Lauder J, Bell JE. Glutathione S-transferase in human brain. Neuropathol Appl Neurobiol. 1990;16:293–303.

    Article  PubMed  CAS  Google Scholar 

  16. Schinkel AH, Wagenaar E, Mol CA, van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest. 1996;97:2517–2524.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Sun H, Dai H, Shaik N, Elmquist WF. Drug efflux transporters in the CNS. Adv Drug Deliv Rev. 2003;55:83–105.

    Article  PubMed  CAS  Google Scholar 

  18. Anderer G, Schrappe M, Brechlin AM, et al. Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia. Pharmacogenetics. 2000;10:715–726.

    Article  PubMed  CAS  Google Scholar 

  19. Reiter A, Schrappe M, Ludwig W-D, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: results and conclusions of the multicenter trial ALL-BFM 86. Blood. 1994;84:3122–3133.

    CAS  PubMed  Google Scholar 

  20. Schrappe M, Reiter A, Ludwig W-D, et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. Blood. 2000;95:3310–3322.

    PubMed  CAS  Google Scholar 

  21. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 1997;18:641–644.

    Article  PubMed  CAS  Google Scholar 

  22. Harris MJ, Coggan M, Langton L, Wilson SR, Board PG. Polymorphism of the Pi class glutathione S-transferase in normal populations and cancer patients. Pharmacogenetics. 1998;8:27–31.

    Article  PubMed  CAS  Google Scholar 

  23. Hennekens CH, Buring JE. Epidemiology in Medicine. Boston: Little, Brown; 1987:295–304.

    Google Scholar 

  24. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002;2:48–58.

    Article  PubMed  CAS  Google Scholar 

  25. Llorente L, Richaud-Patin Y, Diaz-Borjon A, et al. Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders, I: increased P-glycoprotein activity in lymphocytes from rheumatoid arthritis patients might influence disease outcome. Joint Bone Spine. 2000;67:30–39.

    PubMed  CAS  Google Scholar 

  26. Farrell RJ, Murphy A, Long A, et al. High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology. 2000;118:279–288.

    Article  PubMed  CAS  Google Scholar 

  27. Siddiqui A, Kerb R, Weale ME, et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med. 2003;348:1442–1448.

    Article  PubMed  CAS  Google Scholar 

  28. Jamroziak K, Mlynarski W, Balcerczak E, et al. Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur J Haematol. 2004;72:314–321.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Hematology and Oncology, Hannover Medical School, Carl-Neuberg-Str 1, 30625, Hannover, Germany

    Martin Stanulla, Stefan Arens, Anke Rathmann, André Schrauder, Karl Welte & Martin Schrappe

  2. Margarete Fischer-Bosch Institut of Clinical Pharmacology, Stuttgart, Germany

    Elke Schäffeler, Michel Eichelbaum, Ulrich M. Zanger & Matthias Schwab

Authors
  1. Martin Stanulla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elke Schäffeler
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stefan Arens
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anke Rathmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. André Schrauder
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Karl Welte
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michel Eichelbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ulrich M. Zanger
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Martin Schrappe
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Matthias Schwab
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martin Stanulla.

About this article

Cite this article

Stanulla, M., Schäffeler, E., Arens, S. et al. GSTP1 and MDR1 Genotypes and Central Nervous System Relapse in Childhood Acute Lymphoblastic Leukemia. Int J Hematol 81, 39–44 (2005). https://doi.org/10.1532/IJH97.E0418

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1532/IJH97.E0418

Key words

Search

Navigation